Parkinson’s Disease is a chronic and progressive disease of the nervoussystem and it became worse over time. It is the second most common neurologicaldisorder. In ordinary Conditions, nerve cells exhibit in cerebrum and deliversa neurotransmitter called dopamine that oversees a development, feelings, andco-appointment yet because of unhealthy individual dopamine creation, hence theindividual end up with control the development ordinarily. In Germany, has alifetime prevalence of between 0.1 and 0.3% of the population.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21, 2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17, 2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 at Barcelona, Spain | 7th International Congresson Parkinsons and Movement Disorders, November 14-15, 2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society ofIndia; Australian Parkinson’s DiseaseSociety; Movement Disorder Society ofJapan
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
